Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Cannabis banking bill heads to Senate, but future still unclear

Published 04/20/2021, 11:25 AM
Updated 04/20/2021, 11:30 AM
© Reuters. FILE PHOTO: Leaves of a Carmagnola hemp strain plant are silhouetted as the sun sets at a medical cannabis plantation in Trikala

By Shariq Khan

(Reuters) - The U.S. cannabis industry is hoping that the fourth time is a charm for a major banking reform bill that is once again headed to the Senate for approval after a comfortable victory in the U.S. House of Representatives.

The House voted 321-101 on Monday to approve a legislation that would allow banks to provide services to cannabis companies in states where it is legal.

The bill states that proceeds from legitimate cannabis businesses would not be considered illegal and directs federal regulators to craft rules for how they would supervise such banking activity.

Banks have generally been unwilling to do business with companies that sell marijuana or related products, fearing they could run afoul of federal laws.

Cannabis advocacy groups and industry associations are now hoping that a Democrat-led Senate would finally help push the bill through the upper house and to President Joe Biden's desk to be inked into a law.

The bill has been approved thrice in some form by the House in the last three years but failed to make any progress in the Senate, and analysts at brokerage group Cowen & Co voiced some concerns about the roadmap ahead.

"The problem is that Senate Banking Chair Sherrod Brown does not appear interested in advancing the House version of SAFE," the analysts said. "He wants social justice provisions, which we believe put at risk the GOP votes needed to overcome a filibuster."

Shares of Green Thumb Industries (OTC:GTBIF) Inc, Curaleaf Holdings (OTC:CURLF) Inc and Cresco Labs (OTC:CRLBF), pot companies which have the biggest U.S. exposure and stand to benefit most from the bill's passage, rose between 1.5% and 3% in early trading.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"Given the bipartisan support behind the bill, and the fact that we currently have a Senate under Democratic control, the bill's chances of being passed by Senate are definitely better this time around," Jason Wilson, cannabis and banking expert at ETF Managers Group, said.

The National Cannabis Industry Association also said on Monday that advocates are hopeful that Senate Banking Committee Chair will take up the bill in the near future so that it can begin to move through the upper chamber as soon as possible and become law before the end of the year.

Cowen analysts said they believe there are 60 votes for the SAFE Act in the Senate, but added that it believes Senate Democratic leaders are focusing on federal legalization of marijuana ahead of banking access.

Senate Majority Leader Chuck Schumer, in an early-April interview with Politico, said he would try to advance legislation legalizing marijuana use for adults.

Asked about the SAFE Banking Act, he said he would like to see such a bill move forward as part of a more comprehensive measure - even if President Biden was not supportive.

Latest comments

Here’s a thought, if the Democrats are so much more progressive than Republicans, why don’t they decriminalize it?
Better yet why don’t they end the drug war entirely? This would help to solve a lot of the racial dispatities, all in one action of government. Studies support this.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.